Genomics Market

Genomics Market Share & Analysis – Industry Overview

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13620
  • Published Date: Aug, 2023
  • Pages: 236
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Segment Analysis

Regional segmentation analysis

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global genomics market, with a 41.66% share of the market revenue in 2022.

North American region will account for the largest market share with revenue growth. This high market share in North America is attributed to the potential of the US-based firms investing in global genomics revenues. There are many leading pharmaceuticals and research organizations in the US. Also, partnerships are happening among leading organizations in the region. For instance, in January 2022, Illumina Inc. announced its collaboration with Nashville Biosciences, LLC. Asia Pacific is growing at the fastest pace. The surge in the middle class is contributing to the increase in genomics in the region. There is an increase in consumer income along with an increase in awareness and appreciation of health.

North America Region Genomics Market Share in 2022 - 41.66%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Based on one of the studies, the middle-class population in Asia was around 28% of the global population in 2009, and by 2030 it is estimated to be 66% of the global population and around 59% of the global middle-class consumption. There are also many favourable genomics-related policies and investments by Governments in Asia. Also, China's one-child policy made parents in the country very interested in their children's health. There is the use of prenatal genetic testing to identify genetic diseases.

Deliverables Segment Analysis

The deliverables segment is divided into products and services. The product segment dominated the market, with a market share of around 71.33% in 2022. The genomics market is getting competitive with the launch of many new products. Also, there is a surge in the preference for personalized medicine and a decrease in the costs of DNA sequencing, which brought NGS (Next Generation Sequencing) technology, leading to many novel products.

Application & Technology Segment Analysis

The application & technology segment is divided into epigenomics, pathway analysis, functional genomics, biomarker discovery and others. The functional genomics segment dominated the market, with a market share of around 40.23% in 2022. This significant market share is due to growing research revealing the controlling of cognitive disease and behaviours using genetic changes. Many more revelations will emerge regarding genetic regulation and its connection with diseases like Autism Spectrum Disorder (ASD). Also, new TGS technologies help explore the genomes, and it is unparallel to any other technologies; hence it is anticipated that TGS will become the new standard in DNA sequencing.

End User Segment Analysis

The End User segment is divided into pharmaceutical & biotech companies, academic & Government institutes, hospitals & clinics and others. The pharmaceutical & biotech company segment dominated the market, with a market share of around 48.22% in 2022. It is because pharmaceutical and biotech organizations are investing heavily and trying to change the way healthcare is delivered with better patient lives and improved life expectancy. The key users of applied genomics are pharmaceutical organizations.  

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Deliverables
          4.3.2. Market Attractiveness Analysis By Application & Technology
          4.3.3. Market Attractiveness Analysis By End User
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Growing demand for personalized medication
    5.3. Restraints
          5.3.1. High Price
    5.4. Opportunities
          5.4.1. Mental health treatments
    5.5. Challenges
          5.5.1. Economic slowdown

6. Global Genomics Market Analysis and Forecast, By Deliverables
    6.1. Segment Overview
    6.2. Products
    6.3. Services

7. Global Genomics Market Analysis and Forecast, By Application & Technology
    7.1. Segment Overview
    7.2. Epigenomics
    7.3. Pathway Analysis
    7.4. Functional Genomics
    7.5. Biomarker Discovery
    7.6. Others

8. Global Genomics Market Analysis and Forecast, By End User
    8.1. Segment Overview
    8.2. Pharmaceutical & Biotech Company
    8.3. Academic & Government Institutes
    8.4. Hospital & Clinics
    8.5. Others

9. Global Genomics Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global Genomics Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in Global Genomics Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Agilent Technologies
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Eppendorf AG
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. QIAGEN N.V.
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Color Genomics, Inc.
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Danaher Corporation
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Myriad Genetics, Inc.
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Eurofins Scientific
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. BGI Genomics
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Thermo Fisher Scientific, Inc.
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Illumina, Inc.
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
    11.11. Oxford Nanopore Technologies
          11.11.1. Business Overview
          11.11.2. Company Snapshot
          11.11.3. Company Market Share Analysis
          11.11.4. Company Product Portfolio
          11.11.5. Recent Developments
          11.11.6. SWOT Analysis
    11.12. Pacific Biosciences of California, Inc.
          11.12.1. Business Overview
          11.12.2. Company Snapshot
          11.12.3. Company Market Share Analysis
          11.12.4. Company Product Portfolio
          11.12.5. Recent Developments
          11.12.6. SWOT Analysis
    11.13. Quest Diagnostics Incorporated
          11.13.1. Business Overview
          11.13.2. Company Snapshot
          11.13.3. Company Market Share Analysis
          11.13.4. Company Product Portfolio
          11.13.5. Recent Developments
          11.13.6. SWOT Analysis
    11.14. 23andMe, Inc.
          11.14.1. Business Overview
          11.14.2. Company Snapshot
          11.14.3. Company Market Share Analysis
          11.14.4. Company Product Portfolio
          11.14.5. Recent Developments
          11.14.6. SWOT Analysis
    11.15. Bio-Rad Laboratories, Inc.
          11.15.1. Business Overview
          11.15.2. Company Snapshot
          11.15.3. Company Market Share Analysis
          11.15.4. Company Product Portfolio
          11.15.5. Recent Developments
          11.15.6. SWOT Analysis
    11.16. F. Hoffmann-La Roche Ltd.
          11.16.1. Business Overview
          11.16.2. Company Snapshot
          11.16.3. Company Market Share Analysis
          11.16.4. Company Product Portfolio
          11.16.5. Recent Developments
          11.16.6. SWOT Analysis
    11.17. GE Healthcare
          11.17.1. Business Overview
          11.17.2. Company Snapshot
          11.17.3. Company Market Share Analysis
          11.17.4. Company Product Portfolio
          11.17.5. Recent Developments
          11.17.6. SWOT Analysis

List of Table

1. Global Genomics Market, By Deliverables, 2019-2032 (USD Billion)

2. Global Products, Genomics Market, By Region, 2019-2032 (USD Billion) 

3. Global Services, Genomics Market, By Region, 2019-2032 (USD Billion) 

4. Global Genomics Market, By Application & Technology, 2019-2032 (USD Billion) 

5. Global Epigenomics, Genomics Market, By Region, 2019-2032 (USD Billion) 

6. Global Pathway Analysis, Genomics Market, By Region, 2019-2032 (USD Billion) 

7. Global Functional Genomics, Genomics Market, By Region, 2019-2032 (USD Billion) 

8. Global Biomarker Discovery, Genomics Market, By Region, 2019-2032 (USD Billion) 

9. Global Others, Genomics Market, By Region, 2019-2032 (USD Billion) 

10. Global Genomics Market, By End User, 2019-2032 (USD Billion) 

11. Global Pharmaceutical & Biotech Company, Genomics Market, By Region, 2019-2032 (USD Billion) 

12. Global Academic & Government Institutes, Genomics Market, By Region, 2019-2032 (USD Billion) 

13. Global Hospital & Clinics, Genomics Market, By Region, 2019-2032 (USD Billion) 

14. Global Others, Genomics Market, By Region, 2019-2032 (USD Billion) 

15. Global Home Care, Genomics Market, By Region, 2019-2032 (USD Billion) 

16. North America Genomics Market, By Deliverables, 2019-2032 (USD Billion)

17. North America Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

18. North America Genomics Market, By End User, 2019-2032 (USD Billion)

19. U.S. Genomics Market, By Deliverables, 2019-2032 (USD Billion)

20. U.S. Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

21. U.S. Genomics Market, By End User, 2019-2032 (USD Billion)

22. Canada Genomics Market, By Deliverables, 2019-2032 (USD Billion)

23. Canada Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

24. Canada Genomics Market, By End User, 2019-2032 (USD Billion)

25. Mexico Genomics Market, By Deliverables, 2019-2032 (USD Billion)

26. Mexico Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

27. Mexico Genomics Market, By End User, 2019-2032 (USD Billion)

28. Europe Genomics Market, By Deliverables, 2019-2032 (USD Billion)

29. Europe Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

30. Europe Genomics Market, By End User, 2019-2032 (USD Billion)

31. Germany Genomics Market, By Deliverables, 2019-2032 (USD Billion)

32. Germany Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

33. Germany Genomics Market, By End User, 2019-2032 (USD Billion)

34. France Genomics Market, By Deliverables, 2019-2032 (USD Billion)

35. France Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

36. France Genomics Market, By End User, 2019-2032 (USD Billion)

37. U.K. Genomics Market, By Deliverables, 2019-2032 (USD Billion)

38. U.K. Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

39. U.K. Genomics Market, By End User, 2019-2032 (USD Billion)

40. Italy Genomics Market, By Deliverables, 2019-2032 (USD Billion)

41. Italy Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

42. Italy Genomics Market, By End User, 2019-2032 (USD Billion)

43. Spain Genomics Market, By Deliverables, 2019-2032 (USD Billion)

44. Spain Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

45. Spain Genomics Market, By End User, 2019-2032 (USD Billion)

46. Asia Pacific Genomics Market, By Deliverables, 2019-2032 (USD Billion)

47. Asia Pacific Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

48. Asia Pacific Genomics Market, By End User, 2019-2032 (USD Billion)

49. Japan Genomics Market, By Deliverables, 2019-2032 (USD Billion)

50. Japan Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

51. Japan Genomics Market, By End User, 2019-2032 (USD Billion)

52. China Genomics Market, By Deliverables, 2019-2032 (USD Billion)

53. China Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

54. China Genomics Market, By End User, 2019-2032 (USD Billion)

55. India Genomics Market, By Deliverables, 2019-2032 (USD Billion)

56. India Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

57. India Genomics Market, By End User, 2019-2032 (USD Billion)

58. South America Genomics Market, By Deliverables, 2019-2032 (USD Billion)

59. South America Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

60. South America Genomics Market, By End User, 2019-2032 (USD Billion)

61. Brazil Genomics Market, By Deliverables, 2019-2032 (USD Billion)

62. Brazil Genomics Market, By End User, 2019-2032 (USD Billion)

63. Brazil Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

64. Middle East and Africa Genomics Market, By Deliverables, 2019-2032 (USD Billion)

65. Middle East and Africa Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

66. Middle East and Africa Genomics Market, By End User, 2019-2032 (USD Billion)

67. UAE Genomics Market, By Deliverables, 2019-2032 (USD Billion)

68. UAE Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

69. UAE Genomics Market, By End User, 2019-2032 (USD Billion)

70. South Africa Genomics Market, By Deliverables, 2019-2032 (USD Billion)

71. South Africa Genomics Market, By Application & Technology, 2019-2032 (USD Billion)

72. South Africa Genomics Market, By End User, 2019-2032 (USD Billion)

List of Figures 

1. Global Genomics Market Segmentation

2. Global Genomics Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Genomics Market Attractiveness Analysis By Deliverables  

9. Global Genomics Market Attractiveness Analysis By Application & Technology 

10. Global Genomics Market Attractiveness Analysis By End User 

11. Global Genomics Market Attractiveness Analysis By Region

12. Global Genomics Market: Dynamics

13. Global Genomics Market Share By Deliverables (2023 & 2032)

14. Global Genomics Market Share By Application & Technology (2023 & 2032)

15. Global Genomics Market Share By End User (2023 & 2032)

16. Global Genomics Market Share By Regions (2023 & 2032)

17. Global Genomics Market Share By Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global genomics market based on below mentioned segments:

Global Genomics Market by Procedure:

  • Products
  • Services

Global Genomics Market by Application & Technology:

  • Epigenomics
  • Pathway Analysis
  • Functional Genomics
  • Biomarker Discovery
  • Others

Global Genomics Market by End-user:

  • Pharmaceutical & Biotech Company
  • Academic & Government Institutes
  • Hospital & Clinics
  • Others

Global Genomics by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date